MedPath

A randomized, double-blind, parallel controlled clinical study of tangerine peel enzyme in the treatment of insomnia with deficiency of heart and splee

Phase 1
Completed
Conditions
insomnia
Registration Number
ITMCTR2200005639
Lead Sponsor
Guangdong Hospital of traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Over 18 years old.

(2) The diagnosis of chronic insomnia meets the Western medical standard.

(3) It meets the standard of deficiency syndrome of heart and spleen in traditional Chinese medicine.

(4) Pittsburgh sleep quality index (PSQI) total score > 7

(5) Sign informed consent

Exclusion Criteria

(1) People who are ready for pregnancy or during pregnancy or lactation or need to sleep with their children.

(2) According to the medical history and consultation, the doctor confirmed the secondary insomnia caused by other diseases.

For example: local pain, restless legs syndrome, sleep apnea syndrome, acute and chronic heart failure, chronic obstructive pulmonary disease, acute and chronic bronchitis

(3) Patients with moderate and severe depression (total score = 10) were diagnosed according to the patient's self rating depression tool (PHQ-9)

(4) Patients with moderate and severe anxiety were diagnosed according to GAD-7 (total score = 10)

(5) According to the medical history and consultation, the doctor confirmed that the patient needs to be managed according to the disease management mode.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pittsburgh sleep index scale total score;
Secondary Outcome Measures
NameTimeMethod
Patient depression self assessment tool (PHQ-9);Generalized anxiety scale (GAD-7);Insomnia TCM quality of life scale (tcmqli-21);
© Copyright 2025. All Rights Reserved by MedPath